dpy-13 Antibody

What is the dpy-13 gene and what happens when it's mutated?

The dpy-13 gene in C. elegans encodes a member of the collagen multi-gene family that affects body shape. Mutations in dpy-13 result in a short, chunky body shape known as the "dumpy" phenotype. The gene was initially tagged by insertion of the Tc1 transposon, and the wild-type gene was cloned by chromosomal walking 11 kb from ama-1, a gene encoding the large subunit of RNA polymerase II. The DNA sequence reveals that dpy-13 could encode a polypeptide of 302 amino acids, with a 146 base pair sequence (encoding amino acids 56-103) that is unique in the C. elegans genome .

How is dpy-13 expressed during C. elegans development?

The dpy-13 gene belongs to the "intermediate expressed" category of cuticle collagen genes. During each cuticle synthetic period, these genes show peaks of mRNA abundance at approximately 2 hours before the secretion of each new cuticle. This differs from early-expressed collagen genes (including dpy-2, dpy-3, dpy-7, dpy-8, and dpy-10), which peak around 4 hours before cuticle secretion. This temporal expression pattern is repeated during each molting cycle .

What is the relationship between dpy-13 and other collagen genes?

The C. elegans genome contains over 170 predicted cuticular collagen genes, with dpy-13 being just one member of this extensive family. While many collagen genes share high sequence similarity, dpy-13 has unique characteristics. Research shows that mutations in various collagen genes, including dpy-13, can disrupt cuticle morphology in different ways. Interestingly, the products of dpy-3, dpy-5, and dpy-13 are not closely related to one another, suggesting functional specialization within the collagen family .

How can dpy-13 antibodies be generated and validated for research?

For generating antibodies against dpy-13 (or any protein of interest), recombinant protein fragments can be expressed in systems like E. coli using vectors such as pQE-30. The purified protein fragments can then be used to immunize mice or rabbits, and monoclonal cell lines can be generated using standard hybridoma technology .

For validation, researchers should employ multiple strategies:

• Orthogonal validation: Compare immunohistochemistry (IHC) data with RNA expression measurements

• Independent antibody validation: Compare results with those obtained using a second antibody against a different epitope

• Specificity testing: Confirm expected staining patterns in tissues known to express or lack the protein

This multi-faceted approach is particularly important for collagen proteins like dpy-13, which may share structural similarities with other family members .

What are the best methods for creating tagged versions of dpy-13 for localization studies?

Epitope-tagged versions of dpy-13 can be generated using the following protocol:

• Test wild-type clones for functionality by transformation into dpy-13 mutant strains (e.g., CB458)

• Generate a restriction site (such as HindIII) immediately after the region encoding the amino-terminal conserved cysteine residues (domain I)

• Insert annealed oligonucleotides encoding the desired epitope tag (e.g., Ty tag)

• Verify correct orientation by sequencing

• Validate functionality by testing the tagged version's ability to rescue the mutant phenotype

For the Ty tag specifically, oligonucleotides TyA (5′-AGCTTGAGGTCCATACTAACCAAGATCCACTTGACA-3′) and TyB (5′-AGCTTGTCAAGTGGATCTTGGTTAGTATGGACCTCA-3′) can be annealed and inserted at the restriction site .

How can RNAi be used to target dpy-13 effectively?

To construct a dpy-13 RNAi clone:

• Amplify the target region using PCR with primers:

  • Forward: 5′-GGGAAGCTTCGTTCGTTACGGACGTGAC-3′

  • Reverse: 5′-GGGAAGCTTTTAGCGGCGAGTTCCG-3′

• Insert the PCR product into the HindIII site of the L4440 plasmid

• Transform the construct into HT115 E. coli strain

• Induce dsRNA expression and feed to worms following standard RNAi feeding protocols

For studying specific regions or creating dsRNAs with controlled mismatches, synthetic oligonucleotides can be annealed, phosphorylated, and inserted into the expression vector .

How does dpy-13 RNAi affect off-target gene silencing?

Importantly, this superdumpy phenotype occurs even in eri-1(mg366); dpy-13(e458) double mutants (which lack the dpy-13 gene region targeted by RNAi), indicating that the phenotype results from off-target silencing of other collagen genes. A 76-nucleotide fragment from the 3' end of dpy-13 mRNA (called dpy-13g) is sufficient to induce this phenotype. Similar regions from other collagen genes (sqt-3, col-43, col-93, and col-94) can also induce this effect .

What is the role of nuclear RNAi in dpy-13-mediated gene silencing?

The nuclear RNAi pathway contributes significantly to the off-target silencing induced by dpy-13 RNAi. This has been demonstrated through genetic screens that identified suppressors of the superdumpy phenotype:

These results show that mutations in nuclear RNAi pathway components (nrde-2, nrde-3, and rrf-1) suppress the superdumpy phenotype while maintaining normal RNAi responses to other targets. This indicates that the nuclear RNAi pathway is specifically required for off-target silencing but dispensable for canonical RNAi silencing .

How is dpy-13 expression regulated by transcription factors?

The GATA family transcription factor ELT-3 directly regulates dpy-13 expression. ChIP-seq data shows ELT-3 binding sites in the intergenic region of dpy-13, and knockdown of elt-3 decreases dpy-13 expression. This regulation appears to be part of a broader response to environmental stimuli:

• Environmental factors (diet, developmental arrest, population density) influence collagen gene expression

• ELT-3 mediates these changes in response to environmental cues

• Modified collagen expression results in changes to cuticle composition and properties

This regulatory mechanism may allow C. elegans to adapt its cuticle structure to different environmental conditions. For example, exposure to different bacterial diets (E. coli OP50 vs. C. aquatica) or L1 larval arrest conditions changes the expression patterns of dpy-13 and other collagens in an ELT-3-dependent manner .

How can gtsf-1 mutations affect RNAi responses to dpy-13?

Mutations in gtsf-1 (Gametocyte-Specific Factor 1) significantly enhance RNAi sensitivity to dpy-13 and other somatic targets. The table below illustrates this effect:

This indicates that gtsf-1 normally acts to limit RNAi efficacy for somatic targets like dpy-13, while having minimal impact on germline RNAi. This finding has implications for experimental design when using dpy-13 RNAi in different genetic backgrounds .

How do mutations in dpy-13 affect C. elegans body size and morphology?

The dpy-13(e184) reference allele, which carries a small deletion near the middle of the gene, results in a classic dumpy phenotype characterized by a short, chunky body shape. Other alleles, including those with Tc1 transposon insertions near the 5' end of the 1.2 kb transcribed region, produce similar phenotypes. These morphological changes result from alterations in cuticle structure and composition, affecting the mechanical properties of the exoskeleton .

Interestingly, when combined with mutations in genes involved in the DBL-1/BMP-like pathway (which independently regulates body size), dpy-13 mutations can produce complex phenotypic outcomes, suggesting interactions between different body size regulation mechanisms .

How does dpy-13 contribute to environmental adaptation in C. elegans?

Evidence suggests that dpy-13 and other collagens play roles in adapting the cuticle to different environmental conditions:

• Environmental factors (diet, developmental arrest, population density) influence the penetrance of rolling phenotypes in collagen mutants

• These effects are partly due to changes in collagen gene expression mediated by ELT-3

• The cuticle appears to be specialized for different environments through differential collagen expression

For instance, growth on different bacterial diets affects the expression of dpy-13 and other collagens, potentially altering cuticle permeability and mechanical properties. These changes may represent adaptive responses to different environmental challenges, such as pathogen exposure or nutrient availability .

How does dpy-13 expression affect neuronal development?

Recent research has explored how body size genes, including dpy-13, influence neuronal development. Studies of membrane-associated cytoskeleton expansion in neurons reveal that dpy-13 mutations affect this process. In dpy-13(e184) mutants, which show reduced body growth rates and axon stretch-growth rates, there is a mild decrease in the total number of cytoskeletal "hotspots" compared to wild-type animals. This suggests that dpy-13-mediated changes in body size can influence neuronal architecture and development through mechanical coupling between body growth and neuronal expansion .

What controls should be included when using dpy-13 antibodies in immunohistochemistry?

When using dpy-13 antibodies for immunohistochemistry or immunofluorescence:

• Positive controls: Include tissues known to express dpy-13 (based on RNA expression data)

• Negative controls: Include tissues where dpy-13 is not expressed

• Antibody validation controls:

  • Primary antibody omission control

  • Secondary antibody alone control

  • Blocking peptide competition assay

• Genetic controls: Compare staining between wild-type and dpy-13 mutant animals

What factors influence RNAi efficiency when targeting dpy-13?

Several factors can affect the efficiency of dpy-13 RNAi experiments:

• Genetic background: Enhanced RNAi strains (eri-1, ergo-1, etc.) show stronger phenotypes

• dsRNA design: Target sequence, length, and positioning affect efficiency

• Delivery method: Feeding, injection, and soaking methods have different efficiencies

• Temperature: Higher temperatures can enhance RNAi effects

• Developmental stage: Different stages may show different sensitivities

Researchers should also be aware of potential strain-specific differences in RNAi response. For instance, some wild isolates may show different phenotypic responses to RNAi knockdown compared to the standard N2 laboratory strain, which could be due to cryptic genetic variation rather than differences in RNAi efficiency .

How can off-target effects be minimized when using dpy-13 RNAi?

To minimize off-target effects when using dpy-13 RNAi:

• Target unique regions: Design dsRNAs targeting regions with minimal sequence similarity to other collagen genes

• Control dsRNA length: Shorter dsRNAs (30-50 bp) may reduce off-target effects

• Use appropriate genetic backgrounds: Avoid enhanced RNAi backgrounds when studying dpy-13 specifically

• Include controls: Use unrelated RNAi controls and dpy-13 null mutants

• Validate phenotypes: Confirm RNAi phenotypes with genetic mutants when possible

Researchers should be particularly cautious when studying subtle phenotypes, as off-target effects can confound interpretation of results. The 76-nucleotide dpy-13g fragment has been shown to induce significant off-target effects, so avoiding this region in RNAi construct design may be beneficial .